RhumbLine Advisers’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Buy
304,909
+26,435
+9% +$140K ﹤0.01% 1997
2025
Q1
$2.47M Sell
278,474
-11,028
-4% -$97.8K ﹤0.01% 1707
2024
Q4
$3.97M Buy
289,502
+12,144
+4% +$166K ﹤0.01% 1538
2024
Q3
$7.6M Sell
277,358
-6,077
-2% -$166K 0.01% 1195
2024
Q2
$6.93M Buy
283,435
+6,761
+2% +$165K 0.01% 1215
2024
Q1
$5.9M Buy
276,674
+5,452
+2% +$116K 0.01% 1323
2023
Q4
$5.19M Buy
271,222
+1,915
+0.7% +$36.7K 0.01% 1388
2023
Q3
$4.32M Buy
269,307
+1,313
+0.5% +$21.1K 0.01% 1447
2023
Q2
$6.21M Sell
267,994
-980
-0.4% -$22.7K 0.01% 1252
2023
Q1
$6.25M Buy
268,974
+11,282
+4% +$262K 0.01% 1196
2022
Q4
$3.74M Buy
257,692
+11,059
+4% +$160K 0.01% 1446
2022
Q3
$4.71M Buy
246,633
+9,030
+4% +$172K 0.01% 1270
2022
Q2
$4.32M Buy
237,603
+10,562
+5% +$192K 0.01% 1326
2022
Q1
$5.72M Sell
227,041
-786
-0.3% -$19.8K 0.01% 1227
2021
Q4
$6.29M Sell
227,827
-2,443
-1% -$67.4K 0.01% 1236
2021
Q3
$7.44M Sell
230,270
-26,332
-10% -$850K 0.01% 1119
2021
Q2
$7.85M Sell
256,602
-8,099
-3% -$248K 0.01% 1150
2021
Q1
$8.06M Sell
264,701
-110
-0% -$3.35K 0.01% 1131
2020
Q4
$5.24M Buy
264,811
+28,901
+12% +$572K 0.01% 1330
2020
Q3
$3.08M Sell
235,910
-15,076
-6% -$197K ﹤0.01% 1446
2020
Q2
$2.85M Sell
250,986
-14,787
-6% -$168K ﹤0.01% 1530
2020
Q1
$3.8M Buy
265,773
+15,842
+6% +$227K 0.01% 1194
2019
Q4
$6.81M Buy
249,931
+15,208
+6% +$414K 0.01% 1072
2019
Q3
$6.72M Buy
234,723
+13,719
+6% +$393K 0.01% 1021
2019
Q2
$6.14M Buy
221,004
+16,115
+8% +$448K 0.01% 1085
2019
Q1
$6.8M Sell
204,889
-2,172
-1% -$72.1K 0.01% 993
2018
Q4
$6.02M Buy
207,061
+45,070
+28% +$1.31M 0.01% 992
2018
Q3
$7.45M Sell
161,991
-2,378
-1% -$109K 0.01% 849
2018
Q2
$6.14M Sell
164,369
-835
-0.5% -$31.2K 0.01% 965
2018
Q1
$4.88M Buy
165,204
+2,985
+2% +$88.2K 0.01% 1053
2017
Q4
$5.57M Buy
162,219
+24,839
+18% +$853K 0.01% 1003
2017
Q3
$4.97M Buy
137,380
+3,575
+3% +$129K 0.01% 1041
2017
Q2
$3.46M Buy
133,805
+2,047
+2% +$52.9K 0.01% 1225
2017
Q1
$2.53M Buy
131,758
+55,301
+72% +$1.06M 0.01% 1416
2016
Q4
$1.28M Buy
76,457
+4,283
+6% +$71.4K ﹤0.01% 1715
2016
Q3
$1.49M Buy
72,174
+1,584
+2% +$32.6K ﹤0.01% 1596
2016
Q2
$2.16M Buy
70,590
+270
+0.4% +$8.26K 0.01% 1290
2016
Q1
$2.63M Buy
70,320
+1,010
+1% +$37.8K 0.01% 1196
2015
Q4
$2.99M Buy
69,310
+150
+0.2% +$6.47K 0.01% 1119
2015
Q3
$2.59M Buy
69,160
+1,304
+2% +$48.9K 0.01% 1177
2015
Q2
$2.31M Sell
67,856
-1,387
-2% -$47.1K 0.01% 1302
2015
Q1
$2.45M Buy
69,243
+1,650
+2% +$58.4K 0.01% 1260
2014
Q4
$2.3M Sell
67,593
-1,355
-2% -$46.1K 0.01% 1255
2014
Q3
$2.66M Buy
68,948
+287
+0.4% +$11.1K 0.01% 1135
2014
Q2
$2.67M Sell
68,661
-2,820
-4% -$110K 0.01% 1188
2014
Q1
$2.44M Sell
71,481
-4,284
-6% -$146K 0.01% 1220
2013
Q4
$1.59M Sell
75,765
-7,087
-9% -$149K ﹤0.01% 1511
2013
Q3
$1.95M Sell
82,852
-2,044
-2% -$48K 0.01% 1368
2013
Q2
$2.28M Buy
+84,896
New +$2.28M 0.01% 1216